Neurogen Corporation Announces First Quarter 2008 Financial Results

May 8, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug development company focused on improved drugs for psychiatric and neurologic disorders, today announced financial results for the quarter ended March 31, 2008.

Twitter
LinkedIn
Facebook
Email
Print

Earnings